EurekaMag
+ Translate
+ Most Popular
Cunninghamia lanceolata plantations in China
Mammalian lairs in paleo ecological studies and palynology
Studies on technological possibilities in utilization of anhydrous milk fat for production of recombined butter-like products
Should right-sided fibroelastomas be operated upon?
Large esophageal lipoma
Apoptosis in the mammalian thymus during normal histogenesis and under various in vitro and in vivo experimental conditions
Poissons characoides nouveaux ou non signales de l'Ilha do Bananal, Bresil
Desensitizing efficacy of Colgate Sensitive Maximum Strength and Fresh Mint Sensodyne dentifrices
Administration of fluid by subcutaneous infusion: revival of a forgotten method
Tundra mosquito control - an impossible dream?
Schizophrenia for primary care providers: how to contribute to the care of a vulnerable patient population
Geochemical pattern analysis; method of describing the Southeastern limestone regional aquifer system
Incidence of low birth weights in a hospital of Mexico City
Tabanidae
Graded management intensity of grassland systems for enhancing floristic diversity
Microbiology and biochemistry of cheese and fermented milk
The ember tetra: a new pygmy characid tetra from the Rio das Mortes, Brazil, Hyphessobrycon amandae sp. n. (Pisces, Characoidei)
Risk factors of contrast-induced nephropathy in patients after coronary artery intervention
Renovation of onsite domestic wastewater in a poorly drained soil
Observations of the propagation velocity and formation mechanism of burst fractures caused by gunshot
Systolic blood pressure in a population of infants in the first year of life: the Brompton study
Haematological studies in rats fed with metanil yellow
Studies on pasteurellosis. I. A new species of Pasteurella encountered in chronic fowl cholera
Dormancy breaking and germination of Acacia salicina Lindl. seeds
therapy of lupus nephritis. a two-year prospective study

HIV protease inhibitor ritonavir induces cytotoxicity of human endothelial cells


HIV protease inhibitor ritonavir induces cytotoxicity of human endothelial cells



Arteriosclerosis Thrombosis and Vascular Biology 22(10): 1560-1566



ISSN/ISBN: 1079-5642

PMID: 12377730

DOI: 10.1161/01.atv.0000034707.40046.02

Objective: Although HIV protease inhibitors have been successfully used against HIV infection, many metabolic side effects and premature cardiovascular diseases are often associated with this therapy. The mechanisms of these complications are not clear. In this study, we investigated the effect of the HIV protease inhibitor ritonavir on human endothelial cell cultures. Methods and Results: By using nonradioactive cell proliferation and cytotoxicity assays, human endothelial cells treated with ritonavir showed a significant decrease in cell viability and an increase in cytotoxicity in a time- and dose-dependent fashion. Mitochondrial DNA was also substantially damaged with ritonavir treatment by long polymerase chain reaction analysis. In contrast, ritonavir had a very limited effect on endothelial apoptosis, as assessed by analyses of DNA fragmentation and cellular caspase-3 activity. Conclusions: These data demonstrate, for the first time, that the HIV protease inhibitor ritonavir at concentrations near clinical plasma levels is able to directly cause endothelial mitochondrial DNA damage and cell death mainly through necrosis pathways but not through apoptosis. This study suggests that HIV protease inhibitor-mediated endothelial injury may contribute to its cardiovascular complications.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 010730814

Download citation: RISBibTeXText

Related references

The HIV protease inhibitor ritonavir and the proteasome inhibitor bortezomib induce synergistic cytotoxicity on soft tissue sarcoma cells in vitro. Journal of Clinical Oncology 24(18_Suppl): 9566-9566, 2016

Roles and mechanisms of human immunodeficiency virus protease inhibitor ritonavir and other anti-human immunodeficiency virus drugs in endothelial dysfunction of porcine pulmonary arteries and human pulmonary artery endothelial cells. American Journal of Pathology 174(3): 771-781, 2009

The HIV protease inhibitor ritonavir induces expression of heme oxygenase-1 in epithelial-like DLD-1 colon carcinoma cells. FASEB Journal 17(7): C46-C47, 2003

W1950 Ritonavir, a Protease Inhibitor, Induces Apoptosis in Pancreatic Cancer Cells By Inhibiting the Akt Signaling Pathway. Gastroenterology 134(4): A-740, 2008

Ritonavir-saquinavir dual protease inhibitor compared to ritonavir alone in human immunodeficiency virus-infected patients. Antimicrobial Agents and ChemoTherapy 45(12): 3393-3402, 2001

In vitro combination of PNU-140690, a human immunodeficiency virus type 1 protease inhibitor, with ritonavir against ritonavir-sensitive and -resistant clinical isolates. Antimicrobial Agents and ChemoTherapy 41(11): 2367-2373, 1997

In vitro combination of Pnu-140690, a human immunodeficiency virus type 1 protease inhibitor, with ritonavir against ritonavir-sensitive and -resistant clinical isolates. Antimicrobial Agents and Chemotherapy 41(11): 2367-2373, 1997

Human immunodeficiency virus protease inhibitor ritonavir inhibits cholesterol efflux from human macrophage-derived foam cells. American Journal of Pathology 171(1): 304-314, 2007

HIV protease inhibitor ritonavir induces lipoatrophy in male mice. Aids Research and Human Retroviruses 19(12): 1141-1150, 2003

HIV protease inhibitor ritonavir increases endothelial monolayer permeability. Biochemical and Biophysical Research Communications 335(3): 874-882, 2005

The human immunodeficiency virus protease inhibitor ritonavir inhibits lung cancer cells, in part, by inhibition of survivin. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 6(4): 661-670, 2011

LPS induces tyrosine phosphorylation of P38 MAPK in human endothelial cells, and the P38 inhibitor SB203580 inhibits LPS-induced IL-6 release in human umbilical vein endothelial cells. Journal of Endotoxin Research 3(Suppl. 1): 25, 1996

Evolution of human immunodeficiency virus type 1 protease genotypes and phenotypes in vivo under selective pressure of the protease inhibitor ritonavir. Journal of Virology 79(16): 10638-10649, 2005

The protease inhibitor E64d improves ox-LDL-induced endothelial dysfunction in human aortic endothelial cells. Canadian Journal of Physiology and Pharmacology 96(2): 120-127, 2018

Human immunodeficiency virus type 1 protease cleavage site mutations associated with protease inhibitor cross-resistance selected by indinavir, ritonavir, and/or saquinavir. Journal of Virology 75(2): 589-594, 2001